US Hydroxychloroquine, Chloroquine, and Azithromycin Outpatient Prescription Trends, October 2019 Through March 2020

被引：21

作者：

Shehab, Nadine ^{[1
,2
]}

Lovegrove, Maribeth ^{[1
]}

Budnitz, Daniel S. ^{[1
]}

机构：

[1] US Ctr Dis Control & Prevent, US Ctr Dis Control & Prevent COVID 19 Response Te, Natl Ctr Emerging & Zoonot Infect Dis, Div Healthcare Qual Promot, 1600 Clifton Rd NE,Mailstop V18-4, Atlanta, GA 30329 USA

[2] Lantana Consulting Grp, Atlanta, GA USA

来源：

JAMA INTERNAL MEDICINE | 2020年 / 180卷 / 10期

关键词：

D O I：

10.1001/jamainternmed.2020.2594

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1384 / 1386

页数：3

共 6 条

[1]

American Medical Association, JOINT STAT ORD PRESC

[2]

[Anonymous], 2015, FDA Drug Safety Communication: FDA warns that SGLT2 inhibitors for diabetes may result in a serious condition of too much acid in the blood

[3] Internet Searches for Unproven COVID-19 Therapies in the United States [J].